182 related articles for article (PubMed ID: 32719274)
41. Volume and dosimetric variations during two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma.
Wang RH; Zhang SX; Zhou LH; Zhang GQ; Yu H; Lin XD; Lin S
Biomed Mater Eng; 2014; 24(1):1217-25. PubMed ID: 24212016
[TBL] [Abstract][Full Text] [Related]
42. Dose variations in tumor volumes and organs at risk during IMRT for head-and-neck cancer.
Beltran M; Ramos M; Rovira JJ; Perez-Hoyos S; Sancho M; Puertas E; Benavente S; Ginjaume M; Giralt J
J Appl Clin Med Phys; 2012 Nov; 13(6):3723. PubMed ID: 23149770
[TBL] [Abstract][Full Text] [Related]
43. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
[TBL] [Abstract][Full Text] [Related]
44. Will weight loss cause significant dosimetric changes of target volumes and organs at risk in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy?
Chen C; Fei Z; Chen L; Bai P; Lin X; Pan J
Med Dosim; 2014; 39(1):34-7. PubMed ID: 24140235
[TBL] [Abstract][Full Text] [Related]
45. A prospective study of weekly intensity modulated radiation therapy plan adaptation for head and neck cancer: improved target coverage and organ at risk sparing.
Aly F; Miller AA; Jameson MG; Metcalfe PE
Australas Phys Eng Sci Med; 2019 Mar; 42(1):43-51. PubMed ID: 30406923
[TBL] [Abstract][Full Text] [Related]
46. Using overlap volume histogram and IMRT plan data to guide and automate VMAT planning: a head-and-neck case study.
Wu B; Pang D; Simari P; Taylor R; Sanguineti G; McNutt T
Med Phys; 2013 Feb; 40(2):021714. PubMed ID: 23387737
[TBL] [Abstract][Full Text] [Related]
47. A novel surrogate to identify anatomical changes during radiotherapy of head and neck cancer patients.
Gros SA; Xu W; Roeske JC; Choi M; Emami B; Surucu M
Med Phys; 2017 Mar; 44(3):924-934. PubMed ID: 28019647
[TBL] [Abstract][Full Text] [Related]
48. Comparison of Acute Toxicities, Overall Treatment Time and Quality of Life in Head and Neck Cancer Patients Treated with IMRT and Helical Tomotherapy.
R YB; Swamy K; Swaroopa C; Maiya V
Gulf J Oncolog; 2024 May; 1(45):7-14. PubMed ID: 38774928
[TBL] [Abstract][Full Text] [Related]
49. Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer.
Tsuji SY; Hwang A; Weinberg V; Yom SS; Quivey JM; Xia P
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):707-14. PubMed ID: 20231063
[TBL] [Abstract][Full Text] [Related]
50. Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.
Hunter KU; Fernandes LL; Vineberg KA; McShan D; Antonuk AE; Cornwall C; Feng M; Schipper MJ; Balter JM; Eisbruch A
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):676-82. PubMed ID: 24035328
[TBL] [Abstract][Full Text] [Related]
51. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
[TBL] [Abstract][Full Text] [Related]
52. Volume changes during head-and-neck radiotherapy and its impact on the parotid dose - A single-institution observational study.
Ilangovan B; Venkatraman M; Balasundaram S
J Cancer Res Ther; 2020; 16(3):575-580. PubMed ID: 32719270
[TBL] [Abstract][Full Text] [Related]
53. Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation.
Heukelom J; Kantor ME; Mohamed ASR; Elhalawani H; Kocak-Uzel E; Lin T; Yang J; Aristophanous M; Rasch CR; Fuller CD; Sonke JJ
Radiother Oncol; 2020 Jan; 142():100-106. PubMed ID: 31431381
[TBL] [Abstract][Full Text] [Related]
54. A radiobiological and dosimetrical comparison between simultaneous integrated and sequential boost intensity-modulated arc treatment of locally advanced head-and-neck cancer.
Mandal A; Choudhary S; Mani N; Aggarwal SK
J Cancer Res Ther; 2020; 16(3):508-512. PubMed ID: 32719258
[TBL] [Abstract][Full Text] [Related]
55. Reducing Salivary Toxicity with Adaptive Radiotherapy (ReSTART): A Randomized Controlled Trial Comparing Conventional IMRT to Adaptive IMRT in Head and Neck Squamous Cell Carcinomas.
Ghosh Laskar S; Sinha S; Kumar A; Samanta A; Mohanty S; Kale S; Khan F; Lewis Salins S; Murthy V
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):353-361. PubMed ID: 38575432
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of unified intensity-modulated arc therapy for the radiotherapy of head-and-neck cancer.
MacFarlane M; Hoover DA; Wong E; Read N; Palma D; Venkatesan V; Hammond A; Battista JJ; Chen JZ
Radiother Oncol; 2016 May; 119(2):331-6. PubMed ID: 27041142
[TBL] [Abstract][Full Text] [Related]
57. Impact of Adaptive Radiotherapy on Locally Advanced Head and Neck Cancer - A Dosimetric and Volumetric Study.
Dewan A; Sharma S; Dewan A; Srivastava H; Rawat S; Kakria A; Mishra M; T S; Mehrotra K
Asian Pac J Cancer Prev; 2016; 17(3):985-92. PubMed ID: 27039824
[TBL] [Abstract][Full Text] [Related]
58. A study on the impact of patient-related parameters in the ability to spare parotid glands by intensity-modulated radiotherapy for head and neck squamous cell carcinomas.
Bandlamudi BP; Sharan K; Yathiraj PH; Singh A; Reddy A; Fernandes DJ; Srinivasa VM
J Cancer Res Ther; 2018; 14(6):1220-1224. PubMed ID: 30488833
[TBL] [Abstract][Full Text] [Related]
59. Automatic segmentation for adaptive planning in nasopharyngeal carcinoma IMRT: Time, geometrical, and dosimetric analysis.
Fung NTC; Hung WM; Sze CK; Lee MCH; Ng WT
Med Dosim; 2020 Spring; 45(1):60-65. PubMed ID: 31345672
[TBL] [Abstract][Full Text] [Related]
60. Dosimetric Evaluation of Different Intensity-Modulated Radiotherapy Techniques for Breast Cancer After Conservative Surgery.
Zhang F; Wang Y; Xu W; Jiang H; Liu Q; Gao J; Yao B; Hou J; He H
Technol Cancer Res Treat; 2015 Oct; 14(5):515-23. PubMed ID: 25311257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
